By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Mentice publishes the company’s interim report for the period July – Sept 2023

THIRD QUARTER WITH CONTINUED STRONG GROWTH, POSITIVE EBITDA AND IMPROVED CASHFLOW

October 26, 2023
Mentice

THIRD QUARTER WITH CONTINUED STRONG GROWTH, POSITIVE EBITDA AND IMPROVED CASHFLOW


SIGNIFICANT EVENTS DURING THE QUARTER 2023 (JUL – SEP) 

  • Mentice has appointed Henrik Hang as Interim CFO 
  • Mentice has appointed Jonathan Sjöström as the new COO. 
  • Mentice has received a significant order of approx. 0.6 MEUR from a major distributor in APAC. 


THIRD QUARTER 2023 (JUL - SEP) 

  • Order intake amounted to 65.3 (50,2) MSEK, an increase of 30.0%. 
  • Order book by the end of the period was 128.6 (113.9) MSEK, whereof 37.6 MSEK is expected as revenue in 2023. 
  • Net sales amounted to 63.9 (51.1) MSEK, an increase of 25.0%, whereof 19.3% is organic. 
  • Earnings before interest, tax, depreciation, and amortization (EBITDA) amounted to 4.0 (-1.9) MSEK. 
  • Net income for the period amounted to 0.0 (-7.7) MSEK. 
  • Earnings per share (EPS) were 0.0 (-0.30) SEK. 
  • Cash flow from operating activities amounted to 42.3 (-4.1) MSEK.


NINE MONTHS 2023 (JAN – SEP) 

  • Order intake amounted to 200.4 (161,9) MSEK, an increase of 23.7%. 
  • Order book by the end of the period was 128.6 (113.9) MSEK, whereof 39.7 MSEK is expected as revenue in 2023. 
  • Net sales amounted to 203.2 (149.3) MSEK, an increase of 36,1%, whereof 29.9% is organic. 
  • Earnings before interest, tax, depreciation, and amortization (EBITDA) amounted to 21.9 (-15.5) MSEK. 
  • Net income for the period amounted to 0.0 (-32.8) MSEK. 
  • Earnings per share (EPS) were 0.0 (-1.31) SEK. 
  • Cash flow from operating activities amounted to 44.8 (-11.1) MSEK. 



Webcast presentation of the interim report
Date: October 26, 2023
Time: 10:00 CEST

To register for the presentation, please visit https://investor.mentice.com/


Join us today

To always stay on top within the field of medical simulation and its development subscribe to our news and resource list

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.